Gilead Sciences has forged closer ties to its cancer drug partner Arcus Biosciences , although a licensing deal doesn't go as far as the takeover that some market commentators have been predicting.
After hours: January 8 at 5:58:05 PM EST Loading Chart for RCUS ...
Kohl's Corp.-2.39% $1.54B ...
This organization has no public members. You must be a member to see who’s a part of this organization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback